NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00678275,Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia,https://clinicaltrials.gov/study/NCT00678275,,COMPLETED,"This multicenter, prospective phase III-study is to compare the administration of ATG FRESENIUS to the NON-administration of ATG FRESENIUS in a myeloablative conditioning regimen followed by allogeneic hematopoeitic stem cell transplantation from an HLA-identical sibling in patients with acute Leukemia. This clinical trial is to show that the administration of ATG FRESENIUS reduces the risk of chronic Graft-versus-Host disease after allogeneic stem cell transplantation from HLA-identical siblings.",NO,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia,DRUG: ATG FRESENIUS (Anti-Lymphocyte-Globulin)|DRUG: ATG FRESENIUS (Anti-Lymphocyte-Globulin),"comparison of cumulative incidence of chronic GvHD (limited or extensive) after allogeneic SCT from HLA-identical siblings with or without anti-T-lymphocyte-globulin at 2 years after transplantation, 2 years after transplantation","comparison of: acute GvHD/quality of life/treatment-related mortality/toxicity/ overall survival/progression-free survival/engraftment/chronic-GvHD-free survival, 2 years after transplantation|incidence of infection/ AEs and ADRs, 2 years after transplantation",,Universit√§tsklinikum Hamburg-Eppendorf,,ALL,"ADULT, OLDER_ADULT",PHASE3,161,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ATGFamilyStudy,2006-10,2014-02,2015-03,2008-05-15,,2015-05-13,"University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany",
